T

Turnstone Biologics Corp
NASDAQ:TSBX

Watchlist Manager
Turnstone Biologics Corp
NASDAQ:TSBX
Watchlist
Price: 2.66 USD -2.56% Market Closed
Updated: May 20, 2024

Intrinsic Value

Turnstone Biologics Corp is a US-based company operating in Biotechnology industry. [ Read More ]

The intrinsic value of one TSBX stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.66 USD, Turnstone Biologics Corp is hidden .

Key Points:
TSBX Intrinsic Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Backtest
Turnstone Biologics Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TSBX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Turnstone Biologics Corp

Provide an overview of the primary business activities
of Turnstone Biologics Corp.

What unique competitive advantages
does Turnstone Biologics Corp hold over its rivals?

What risks and challenges
does Turnstone Biologics Corp face in the near future?

Has there been any significant insider trading activity
in Turnstone Biologics Corp recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Turnstone Biologics Corp.

Provide P/S
for Turnstone Biologics Corp.

Provide P/E
for Turnstone Biologics Corp.

Provide P/OCF
for Turnstone Biologics Corp.

Provide P/FCFE
for Turnstone Biologics Corp.

Provide P/B
for Turnstone Biologics Corp.

Provide EV/S
for Turnstone Biologics Corp.

Provide EV/GP
for Turnstone Biologics Corp.

Provide EV/EBITDA
for Turnstone Biologics Corp.

Provide EV/EBIT
for Turnstone Biologics Corp.

Provide EV/OCF
for Turnstone Biologics Corp.

Provide EV/FCFF
for Turnstone Biologics Corp.

Provide EV/IC
for Turnstone Biologics Corp.

Show me price targets
for Turnstone Biologics Corp made by professional analysts.

What are the Revenue projections
for Turnstone Biologics Corp?

How accurate were the past Revenue estimates
for Turnstone Biologics Corp?

What are the Net Income projections
for Turnstone Biologics Corp?

How accurate were the past Net Income estimates
for Turnstone Biologics Corp?

What are the EPS projections
for Turnstone Biologics Corp?

How accurate were the past EPS estimates
for Turnstone Biologics Corp?

What are the EBIT projections
for Turnstone Biologics Corp?

How accurate were the past EBIT estimates
for Turnstone Biologics Corp?

Compare the revenue forecasts
for Turnstone Biologics Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Turnstone Biologics Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Turnstone Biologics Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Turnstone Biologics Corp compared to its peers.

Compare the P/E ratios
of Turnstone Biologics Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Turnstone Biologics Corp with its peers.

Analyze the financial leverage
of Turnstone Biologics Corp compared to its main competitors.

Show all profitability ratios
for Turnstone Biologics Corp.

Provide ROE
for Turnstone Biologics Corp.

Provide ROA
for Turnstone Biologics Corp.

Provide ROIC
for Turnstone Biologics Corp.

Provide ROCE
for Turnstone Biologics Corp.

Provide Gross Margin
for Turnstone Biologics Corp.

Provide Operating Margin
for Turnstone Biologics Corp.

Provide Net Margin
for Turnstone Biologics Corp.

Provide FCF Margin
for Turnstone Biologics Corp.

Show all solvency ratios
for Turnstone Biologics Corp.

Provide D/E Ratio
for Turnstone Biologics Corp.

Provide D/A Ratio
for Turnstone Biologics Corp.

Provide Interest Coverage Ratio
for Turnstone Biologics Corp.

Provide Altman Z-Score Ratio
for Turnstone Biologics Corp.

Provide Quick Ratio
for Turnstone Biologics Corp.

Provide Current Ratio
for Turnstone Biologics Corp.

Provide Cash Ratio
for Turnstone Biologics Corp.

What is the historical Revenue growth
over the last 5 years for Turnstone Biologics Corp?

What is the historical Net Income growth
over the last 5 years for Turnstone Biologics Corp?

What is the current Free Cash Flow
of Turnstone Biologics Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Turnstone Biologics Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Turnstone Biologics Corp

Current Assets 102.6m
Cash & Short-Term Investments 94.8m
Receivables 194k
Other Current Assets 7.6m
Non-Current Assets 10.3m
PP&E 9.1m
Other Non-Current Assets 1.1m
Current Liabilities 12m
Accounts Payable 36k
Accrued Liabilities 11.9m
Non-Current Liabilities 2.2m
Other Non-Current Liabilities 2.2m
Efficiency

Earnings Waterfall
Turnstone Biologics Corp

Revenue
19.3m USD
Operating Expenses
-78.3m USD
Operating Income
-59m USD
Other Expenses
3.8m USD
Net Income
-55.2m USD

Free Cash Flow Analysis
Turnstone Biologics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

TSBX Profitability Score
Profitability Due Diligence

Turnstone Biologics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Turnstone Biologics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

TSBX Solvency Score
Solvency Due Diligence

Turnstone Biologics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Turnstone Biologics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TSBX Price Targets Summary
Turnstone Biologics Corp

Wall Street analysts forecast TSBX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TSBX is 13.26 USD with a low forecast of 6.06 USD and a high forecast of 21 USD.

Lowest
Price Target
6.06 USD
128% Upside
Average
Price Target
13.26 USD
398% Upside
Highest
Price Target
21 USD
689% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Turnstone Biologics Corp

Ownership

TSBX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

TSBX Price
Turnstone Biologics Corp

1M 1M
-9%
6M 6M
-12%
1Y 1Y
-78%
3Y 3Y
-78%
5Y 5Y
-78%
10Y 10Y
-78%
Annual Price Range
2.66
52w Low
1.8
52w High
12.95
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -86%
Shares Statistics
Market Capitalization 61.5m USD
Shares Outstanding 23 130 000
Percentage of Shares Shorted 6.44%

TSBX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Turnstone Biologics Corp

Country

United States of America

Industry

Biotechnology

Market Cap

61.5m USD

Dividend Yield

0%

Description

Turnstone Biologics Corp is a US-based company operating in Biotechnology industry. The company is headquartered in La Jolla, California and currently employs 108 full-time employees. The company went IPO on 2023-07-21. Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The firm is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient’s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function.

Contact

CALIFORNIA
La Jolla
9310 Athena Circle, Suite 300
+13478975988
https://www.turnstonebio.com

IPO

2023-07-21

Employees

108

Officers

President, CEO & Director
Dr. Sammy J. Farah M.B.A., Ph.D.
Chief Financial Officer
Dr. Venkat Ramanan Ph.D.
Interim Chief Medical Officer & Executive Director
Dr. Michael F. Burgess M.D., MBChB, Ph.D.
Chief Business Officer
Ms. Saryah Azmat
Interim Chief Technology Officer
Dr. Vijay Chiruvolu M.B.A., Ph.D.
Chief Scientific Officer
Dr. Stewart Abbot Ph.D.

See Also

Discover More
What is the Intrinsic Value of one TSBX stock?

The intrinsic value of one TSBX stock under the Base Case scenario is hidden USD.

Is TSBX stock undervalued or overvalued?

Compared to the current market price of 2.66 USD, Turnstone Biologics Corp is hidden .